EPS Bio (Taiwan) Performance
| 4183 Stock | TWD 16.20 0.05 0.31% |
The firm shows a Beta (market volatility) of 0.4, which means possible diversification benefits within a given portfolio. As returns on the market increase, EPS Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding EPS Bio is expected to be smaller as well. At this point, EPS Bio Technology has a negative expected return of -0.15%. Please make sure to confirm EPS Bio's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if EPS Bio Technology performance from the past will be repeated at future time.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days EPS Bio Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors. ...more
| Quick Ratio | 2.14 | |
| Fifty Two Week Low | 13.65 | |
| Payout Ratio | 17.24% | |
| Fifty Two Week High | 20.25 | |
| Trailing Annual Dividend Yield | 4.09% |
EPS |
EPS Bio Relative Risk vs. Return Landscape
If you would invest 1,795 in EPS Bio Technology on October 27, 2025 and sell it today you would lose (175.00) from holding EPS Bio Technology or give up 9.75% of portfolio value over 90 days. EPS Bio Technology is generating negative expected returns and assumes 1.5065% volatility on return distribution over the 90 days horizon. Simply put, 13% of stocks are less volatile than EPS, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
EPS Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EPS Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EPS Bio Technology, and traders can use it to determine the average amount a EPS Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Estimated Market Risk
| 1.51 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average EPS Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EPS Bio by adding EPS Bio to a well-diversified portfolio.
EPS Bio Fundamentals Growth
EPS Stock prices reflect investors' perceptions of the future prospects and financial health of EPS Bio, and EPS Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EPS Stock performance.
| Return On Equity | 14.88 | |||
| Return On Asset | 4.42 | |||
| Profit Margin | 9.33 % | |||
| Operating Margin | 7.56 % | |||
| Current Valuation | 345.41 M | |||
| Shares Outstanding | 23.8 M | |||
| Price To Earning | 9.74 X | |||
| Price To Book | 1.36 X | |||
| Price To Sales | 0.90 X | |||
| Revenue | 444.68 M | |||
| EBITDA | 46.92 M | |||
| Cash And Equivalents | 202.58 M | |||
| Cash Per Share | 8.51 X | |||
| Total Debt | 141.01 M | |||
| Debt To Equity | 47.60 % | |||
| Book Value Per Share | 12.43 X | |||
| Cash Flow From Operations | 37.37 M | |||
| Earnings Per Share | 1.74 X | |||
About EPS Bio Performance
Evaluating EPS Bio's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if EPS Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if EPS Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
EPS Bio Technology Corp. manufactures and sells OEMODM glucose meters and strips in Taiwan. The company also exports its products to approximately 25 countries, including North America, Europe, the Middle East, South Asia, China, and South East Asia. EPS BIO is traded on Taiwan OTC Exchange in Taiwan.Things to note about EPS Bio Technology performance evaluation
Checking the ongoing alerts about EPS Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EPS Bio Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EPS Bio Technology generated a negative expected return over the last 90 days |
- Analyzing EPS Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EPS Bio's stock is overvalued or undervalued compared to its peers.
- Examining EPS Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EPS Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EPS Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EPS Bio's stock. These opinions can provide insight into EPS Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for EPS Stock Analysis
When running EPS Bio's price analysis, check to measure EPS Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EPS Bio is operating at the current time. Most of EPS Bio's value examination focuses on studying past and present price action to predict the probability of EPS Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EPS Bio's price. Additionally, you may evaluate how the addition of EPS Bio to your portfolios can decrease your overall portfolio volatility.